Search results
Wall Street Analysts See a 468.83% Upside in Anavex Life Sciences (AVXL): Can the Stock Really Move...
Zacks via Yahoo Finance· 5 months agoThe mean of analysts' price targets for Anavex Life Sciences (AVXL) points to a 468.8% upside in the...
Is Anavex Life Sciences (AVXL) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 11 months agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why
Zacks via Yahoo Finance· 3 months agoAnavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing...
Anavex (AVXL) Up 12% on Regulatory Update for Alzheimer's Drug
Zacks via Yahoo Finance· 6 months agoAnavex (AVXL) announces an encouraging regulatory update for its investigational candidate,...
Anavex Catapults On Alzheimer's Results — What The CEO Says Critics Got Wrong
Investor's Business Daily· 1 year agoAnavex Life Sciences says its experimental Alzheimer's treatment met the goals of a midstage study,...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 8 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoAnavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex...
Is Anavex Life Sciences Stock a Buy Now?
Motley Fool· 1 year agoAnavex Life Sciences (NASDAQ: AVXL) is a small-cap stock with big ambitions. It has a potential Alzheimer's treatment that fared well in recent trials...
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo Finance· 4 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
Zacks via Yahoo Finance· 5 months agoThe CHMP agrees that Anavex's (AVXL) blarcamesine for Alzheimer's disease is eligible for submission...